TrialAtherosclerosis2009

Efficacy and safety of ABT-335 (fenofibric acid) in combination with rosuvastatin in patients with mixed dyslipidemia: a phase 3 study.

Peter H Jones et al.PubMed ↗Publisher ↗

No numbers read from the abstract.